Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Neurofibromatosis Type 1
Total 0 results
Nothing found
Sponsors and Collaborators
Nutrabolt
Zhongda Hospital, Medical School, Southeast University
Ministry of Public Health, Cameroon
Defence Services Medical Academy (DSMA), Myanmar
Vivid Pharma Inc.
Health Information Technology Solutions (HITS) LLC
HBSA
Université de Genève (UNIGE)
Impulse Dynamics, Inc.
Smart Meter Corporation
Huisartspraktijk Handellaan
Pia Jaeger, MD, PhD
Hungarian Dental Association
Cogniciti
Shanghai GeneChem Co., Ltd.
BioNova Pharmaceuticals (Shanghai) LTD.
NERv Technology Inc
Salena Killion
The Affiliated Hospital of Xuzhou Medical University
UNITI Consortium
View Full List
Medical Conditions
Failed Induction
Vertebral Compression Fractures in Osteoporotic Patients
Endoleaks
Infection, Bacterial
Biomarkers, Pharmacological
Alzheimer Disease Focal
Cardiovascular Primary Prevention
Immediate Implant Placement
PPA Syndrome
Radiofrequency Ablation Treatment
VEXAS Syndrome
Eye Disease, Hereditary
Premature Rupture of Membranes Prolonged
Pain, Breakthrough
Research Mentoring Skills
Old Age (Focus; Not a Recognized Condition)
Cerebral Arterial Disease
Advanced Bladder Carcinoma
SMA - Spinal Muscular Atrophy
PET-CT Specimen Imager
View Full List
Drug Interventions
Cefadroxil until drain removal
OXP005
Oxymorphone hydrochloride (HCl)
Acetylsalicylic acid
80% oxygen
TQB2450
Durvalumab + chemotherapy treatment
0.75% Ropivacaine
Rosuvastatin
5 FU continuous
CJ-12420 200mg + Clarithromycin 500mg
Lacosamide
CNTO 6785 50 mg
HPN328
18F-FDG
Phase B: Triplixam / Elestar HCT
20 mg/kg IV FL-301
Microneedling with topical glycolic acid 35%.
INT-747
Olopatadine hydrochloride 0.2%
View Full List
CROs by country
Contract Research Organizations in Bangladesh
Contract Research Organizations in Cambodia
Contract Research Organizations in Canada
Contract Research Organizations in Croatia
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Greece
Contract Research Organizations in Guinea
Contract Research Organizations in India
Contract Research Organizations in Iran
Contract Research Organizations in Jamaica
Contract Research Organizations in Jordan
Contract Research Organizations in Myanmar
Contract Research Organizations in Senegal
CRO list by country
CROs in Burundi
SGS
All CROs in Burundi
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe